Circulating Matrix Metalloproteinases and Their Inhibitors in Premature Coronary AtherosclerosisYoshihiro Noji, Hiroshi Mabuchi, Kouji Kajinami et al.|Clinical Chemistry and Laboratory Medicine (CCLM)|2001Cited by 151
Apolipoprotein composition of HDL in cholesteryl ester transfer protein deficiencyBela F. Asztalos, Hiroshi Mabuchi, Katalin V. Horvath et al.|Journal of Lipid Research|2004Cited by 96
Long-term treatment with pitavastatin (NK-104), a new HMG-CoA reductase inhibitor, of patients with heterozygous familial hypercholesterolemiaYoshihiro Noji, Hiroshi Mabuchi, Toshinori Higashikata et al.|Atherosclerosis|2002Cited by 74
Abetalipoproteinemia Caused by Maternal Isodisomy of Chromosome 4q Containing an Intron 9 Splice Acceptor Mutation in the Microsomal Triglyceride Transfer Protein GeneXiao Yang, Hiroshi Mabuchi, Akihiro Inazu et al.|Arteriosclerosis Thrombosis and Vascular Biology|1999Cited by 70
Effects of serum B vitamins on elevated plasma homocysteine levels associated with the mutation of methylenetetrahydrofolate reductase gene in JapaneseYuri Moriyama, Hiroshi Mabuchi, Hideyoshi Suzuki et al.|Atherosclerosis|2002Cited by 56